Impact of the Glucagon Assay When Assessing the Effect of Chronic Liraglutide Therapy on Glucagon Secretion

The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial

(2015) Caroline K. Kramer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Stability of glucagon-like peptide 1 and glucagon in human plasma

(2015) N. J. Wewer Albrechtsen et al.   Endocrine Connections

Glycemic Variability in Patients With Early Type 2 Diabetes: The Impact of Improvement in β-Cell Function

(2014) Caroline K. Kramer et al.   DIABETES CARE

Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial

(2014) Ravi Retnakaran et al.   DIABETES CARE

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

(2014) Nicolai J. Wewer Albrechtsen et al.   DIABETOLOGIA

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

(2014) Monika J Bak et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY